Can helminths or helminth-derived products be used in humans to prevent or treat allergic diseases?

Trends in Immunology

Volumn 30, Issue 2, 2009, Pages 75-82

  Erb, Klaus J ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTHELMINTIC AGENT; ANTIALLERGIC AGENT; ANTIHISTAMINIC AGENT; CYSTATIN; CYTOKINE; ES 62; HELMINTH EXTRACT; HELMINTH PROTEIN; INTERLEUKIN 10; LYSOPHOSPHATIDYLSERINE; NATURAL PRODUCT; PARASITE ANTIGEN; STEROID; THIOREDOXIN PEROXIDASE; THIOREDOXIN PEROXIDE; UNCLASSIFIED DRUG;

ALLERGIC DISEASE; ALLERGIC REACTION; ANAPHYLAXIS; ANTIGEN PRESENTING CELL; ARTICLE; ASCARIS SUUM; CELL ACTIVATION; CELLULAR IMMUNITY; CROSS REACTION; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE EXACERBATION; DRUG HYPERSENSITIVITY; DRUG SAFETY; ENTERITIS; HELMINTH; HELMINTHIASIS; HUMAN; INFECTION SENSITIVITY; NONHUMAN; PHENOTYPE; REGULATORY T LYMPHOCYTE; RESPIRATORY TRACT ALLERGY; SENSITIZATION; TH1 CELL; TH2 CELL; TRICHURIS;

ANIMALS; ANTIGENS, HELMINTH; CELL EXTRACTS; CROSS REACTIONS; HELMINTH PROTEINS; HELMINTHIASIS; HELMINTHS; HUMANS; HYPERSENSITIVITY; IMMUNE TOLERANCE; IMMUNOLOGIC FACTORS; INTERLEUKIN-10; MICE; T-LYMPHOCYTES, REGULATORY; TH2 CELLS;

EID: 60649092308     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2008.11.005     Document Type: Article

References (71)

1. Barnes P.J. Immunology of asthma and chronic obstructive pulmonary disease. Nat. Rev. Immunol. 8 (2008) 183-192
2. Wohlleben G., and Erb K.J. Atopic disorders: a vaccine around the corner?. Trends Immunol. 22 (2001) 618-626
3. Strachan D.P. Hay fever, hygiene, and household size. BMJ 299 (1989) 1259-1260
4. Erb K.J. Atopic disorders: a default pathway in the absence of infection?. Immunol. Today 20 (1999) 317-322
5. Erb K.J., and Wohlleben G. Novel vaccines protecting against the development of allergic disorders: a double-edged sword?. Curr. Opin. Immunol. 14 (2002) 633-643
6. Kamradt T., et al. Induction, exacerbation and inhibition of allergic and autoimmune diseases by infection. Trends Immunol. 26 (2005) 260-267
7. Maizels R.M., and Yazdanbakhsh M. Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat. Rev. Immunol. 3 (2003) 733-744
8. Yazdanbakhsh M., et al. Allergy, parasites, and the hygiene hypothesis. Science 296 (2002) 490-494
9. Hamelmann E., et al. Primary prevention of allergy: avoiding risk or providing protection?. Clin. Exp. Allergy 38 (2008) 233-245
10. Fallon P.G., and Mangan N.E. Suppression of TH2-type allergic reactions by helminth infection. Nat. Rev. Immunol. 7 (2007) 220-230
11. Cooper P.J., et al. Reduced risk of atopy among school-age children infected with geohelminth parasites in a rural area of the tropics. J. Allergy Clin. Immunol. 111 (2003) 995-1000
12. Huang S.L., et al. Negative association of Enterobius infestation with asthma and rhinitis in primary school children in Taipei. Clin. Exp. Allergy 32 (2002) 1029-1032
13. Lynch N.R., et al. Allergic reactivity and socio-economic level in a tropical environment. Clin. Allergy 17 (1987) 199-207
14. Nyan O.A., et al. Atopy, intestinal helminth infection and total serum IgE in rural and urban adult Gambian communities. Clin. Exp. Allergy 31 (2001) 1672-1678
15. Scrivener S., et al. Independent effects of intestinal parasite infection and domestic allergen exposure on risk of wheeze in Ethiopia: a nested case-control study. Lancet 358 (2001) 1493-1499
16. Schafer T., et al. Worm infestation and the negative association with eczema (atopic/nonatopic) and allergic sensitization. Allergy 60 (2005) 1014-1020
17. Araujo M.I., et al. Inverse association between skin response to aeroallergens and Schistosoma mansoni infection. Int. Arch. Allergy Immunol. 123 (2000) 145-148
18. Medeiros M., et al. Schistosoma mansoni infection is associated with a reduced course of asthma. J. Allergy Clin. Immunol. 111 (2003) 947-951
19. van den Biggelaar A.H., et al. Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10. Lancet 356 (2000) 1723-1727
20. Wordemann M., et al. Association of atopy, asthma, allergic rhinoconjunctivitis, atopic dermatitis and intestinal helminth infections in Cuban children. Trop. Med. Int. Health 13 (2008) 180-186
21. van den Biggelaar A.H., et al. Long-term treatment of intestinal helminths increases mite skin-test reactivity in Gabonese schoolchildren. J. Infect. Dis. 189 (2004) 892-900
22. Lynch N.R., et al. Effect of antihelmintic treatment on the allergic reactivity of children in a tropical slum. J. Allergy Clin. Immunol. 92 (1993) 404-411
23. Borkow G., et al. Chronic immune activation associated with intestinal helminth infections results in impaired signal transduction and anergy. J. Clin. Invest. 106 (2000) 1053-1060
24. Wang C.C., et al. Infection of mice with the helminth Strongyloides stercoralis suppresses pulmonary allergic responses to ovalbumin. Clin. Exp. Allergy 31 (2001) 495-503
25. Bashir M.E., et al. An enteric helminth infection protects against an allergic response to dietary antigen. J. Immunol. 169 (2002) 3284-3292
26. Kitagaki K., et al. Intestinal helminths protect in a murine model of asthma. J. Immunol. 177 (2006) 1628-1635
27. Wilson M.S., et al. Suppression of allergic airway inflammation by helminth-induced regulatory T cells. J. Exp. Med. 202 (2005) 1199-1212
28. Wohlleben G., et al. Helminth infection modulates the development of allergen-induced airway inflammation. Int. Immunol. 16 (2004) 585-596
29. Dittrich A.M., et al. Helminth Infection with Litomosoides sigmodontis induces regulatory T cells and inhibits allergic sensitization, airway inflammation, and hyperreactivity in a murine asthma model. J. Immunol. 180 (2008) 1792-1799
30. Mangan N.E., et al. Helminth-modified pulmonary immune response protects mice from allergen-induced airway hyperresponsiveness. J. Immunol. 176 (2006) 138-147
31. Smits H.H., et al. Protective effect of Schistosoma mansoni infection on allergic airway inflammation depends on the intensity and chronicity of infection. J. Allergy Clin. Immunol. 120 (2007) 932-940
32. Lynch N.R., et al. Clinical improvement of asthma after anthelminthic treatment in a tropical situation. Am. J. Respir. Crit. Care Med. 156 (1997) 50-54
33. Dold S., et al. Ascaris-specific IgE and allergic sensitization in a cohort of school children in the former East Germany. J. Allergy Clin. Immunol. 102 (1998) 414-420
34. Buijs J., et al. Relationship between allergic manifestations and Toxocara seropositivity: a cross-sectional study among elementary school children. Eur. Respir. J. 10 (1997) 1467-1475
35. Takeuchi H., et al. High titre of anti-Ascaris immunoglobulin E associated with bronchial asthma symptoms in 5-year-old rural Bangladeshi children. Clin. Exp. Allergy 38 (2008) 276-282
36. Demirci M., et al. Tissue parasites in patients with chronic urticaria. J. Dermatol. 30 (2003) 777-781
37. Coyle A.J., et al. Eosinophils are not required to induce airway hyperresponsiveness after nematode infection. Eur. J. Immunol. 28 (1998) 2640-2647
38. Hall L.R., et al. An essential role for interleukin-5 and eosinophils in helminth-induced airway hyperresponsiveness. Infect. Immun. 66 (1998) 4425-4430
39. Pinelli E., et al. Infection with the roundworm Toxocara canis leads to exacerbation of experimental allergic airway inflammation. Clin. Exp. Allergy 38 (2008) 649-658
40. Strait R.T., et al. IL-4 Exacerbates anaphylaxis. J. Immunol. 170 (2003) 3835-3842
41. Hurst S.D., et al. Modulation of inhaled antigen-induced IgE tolerance by ongoing Th2 responses in the lung. J. Immunol. 166 (2001) 4922-4930
42. Hahn C., and Erb K.J. The preclinical testing strategy for the development of novel chemical entities for the treatment of asthma. Curr. Drug Targets 9 (2008) 443-451
43. Leonardi-Bee J., et al. Asthma and current intestinal parasite infection: systematic review and meta-analysis. Am. J. Respir. Crit. Care Med. 174 (2006) 514-523
44. Finney C.A., et al. Expansion and activation of CD4(+)CD25(+) regulatory T cells in Heligmosomoides polygyrus infection. Eur. J. Immunol. 37 (2007) 1874-1886
45. Herz U., et al. The influence of infections on the development and severity of allergic disorders. Curr. Opin. Immunol. 12 (2000) 632-640
46. Trujillo-Vargas C.M., et al. Helminth-derived products inhibit the development of allergic responses in mice. Am. J. Respir. Crit. Care Med. 175 (2007) 336-344
47. Schnoeller C., et al. A helminth immunomodulator reduces allergic and inflammatory responses by induction of IL-10-producing macrophages. J. Immunol. 180 (2008) 4265-4272
48. Taylor M.D., et al. F4/80+ alternatively activated macrophages control CD4+ T cell hyporesponsiveness at sites peripheral to filarial infection. J. Immunol. 176 (2006) 6918-6927
49. Erb K.J. Helminths, allergic disorders and IgE-mediated immune responses: where do we stand?. Eur. J. Immunol. 37 (2007) 1170-1173
50. Doetze A., et al. Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by T(h)3/T(r)1-type cytokines IL-10 and transforming growth factor-beta but not by a T(h)1 to T(h)2 shift. Int. Immunol. 12 (2000) 623-630
51. Satoguina J., et al. Antigen-specific T regulatory-1 cells are associated with immunosuppression in a chronic helminth infection (onchocerciasis). Microbes Infect. 4 (2002) 1291-1300
52. Harnett W., and Harnett M.M. Therapeutic immunomodulators from nematode parasites. Expert Rev. Mol. Med. 10 (2008) e18
53. Lima C., et al. Eosinophilic inflammation and airway hyper-responsiveness are profoundly inhibited by a helminth (Ascaris suum) extract in a murine model of asthma. Clin. Exp. Allergy 32 (2002) 1659-1666
54. Itami D.M., et al. Modulation of murine experimental asthma by Ascaris suum components. Clin. Exp. Allergy 35 (2005) 873-879
55. Melendez A.J., et al. Inhibition of FceRI-mediated mast cell responses by ES-62, a product of parasitic filarial nematodes. Nat. Med. 13 (2007) 1375-1381
56. McInnes I.B., et al. A novel therapeutic approach targeting articular inflammation using the filarial nematode-derived phosphorylcholine-containing glycoprotein ES-62. J. Immunol. 171 (2003) 2127-2133
57. Imai S., and Fujita K. Molecules of parasites as immunomodulatory drugs. Curr. Top. Med. Chem. 4 (2004) 539-552
58. van der Kleij D., et al. A novel host-parasite lipid cross-talk. Schistosomal Lyso-Phosphatidylserine activates Toll-like receptor 2 and affects immune polarization. J. Biol. Chem. 277 (2002) 48122-48129
59. Donnelly S., et al. Thioredoxin peroxidase secreted by Fasciola hepatica induces the alternative activation of macrophages. Infect. Immun. 73 (2005) 166-173
60. Mortimer K., et al. Dose-ranging study for trials of therapeutic infection with Necator americanus in humans. Am. J. Trop. Med. Hyg. 75 (2006) 914-920
61. Summers R.W., et al. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Am. J. Gastroenterol. 98 (2003) 2034-2041
62. Summers R.W., et al. Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 128 (2005) 825-832
63. Zaccone P., et al. Interplay of parasite-driven immune responses and autoimmunity. Trends Parasitol. 24 (2008) 35-42
64. Hunter M.M., et al. Helminth infection enhances disease in a murine TH2 model of colitis. Gastroenterology 132 (2007) 1320-1330
65. Kradin R.L., et al. Iatrogenic Trichuris suis infection in a patient with Crohn disease. Arch. Pathol. Lab. Med. 130 (2006) 718-720
66. Pedersen S., and Saeed I. Host age influence on the intensity of experimental Trichuris suis infection in pigs. Parasite 9 (2002) 75-79
67. Belkaid Y. Regulatory T cells and infection: a dangerous necessity. Nat. Rev. Immunol. 7 (2007) 875-888
68. Demeure C.E., et al. Resistance to Schistosoma mansoni in humans: influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy. J. Infect. Dis. 168 (1993) 1000-1008
69. Santos A.B., et al. Cross-reactive IgE antibody responses to tropomyosins from Ascaris lumbricoides and cockroach. J. Allergy Clin. Immunol. 121 (2008) 1040-1046
70. Donnelly S., et al. Proteases in helminth- and allergen- induced inflammatory responses. Chem. Immunol. Allergy 90 (2006) 45-64
71. Werner-Klein M., et al. Sublingual immunotherapy of allergic diseases. Expert Opin. Drug Deliv. 3 (2006) 599-612